Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2 Pt 1
|
pubmed:dateCreated |
1998-3-16
|
pubmed:abstractText |
Experimental studies have implicated a functional role for the extracellular matrix glycoprotein thrombospondin-1 (TSP-1) in vascular smooth muscle cell proliferation and migration. We therefore sought to determine if TSP-1 might represent a specific component of the fibroproliferative tissue typically associated with restenosis lesions from human coronary and peripheral arteries. Positive immunostaining for TSP-1 was limited to hypocellular plaques typical of primary atherosclerosis; in contrast, such staining was nearly absent from the loose extracellular matrix of the fibroproliferative tissue typical of restenotic lesions. Only a small fraction of vascular smooth muscle cells in either primary or restenotic lesions demonstrated a cellular staining pattern for TSP-1, which was also observed in control studies performed in cell culture and in atherosclerotic rabbit arteries examined 3 days after experimental balloon angioplasty. Double-staining for TSP-1 and proliferating cell nuclear antigen in studies of human beings disclosed that only a small portion of proliferating cell nuclear antigen-positive cells also stained for TSP-1. The observations made in this series of specimens thus indicate that TSP-1 is not a major component of the extracellular matrix of human restenotic tissues, even when such specimens demonstrate evidence of hypercellularity or ongoing cellular proliferation. Because most restenosis specimens, however, were retrieved > or =1 month after the primary intervention, a functional role for TSP-1 in smooth muscle cell proliferation or migration at the early stages of lesion development is still possible.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0002-8703
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
135
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
357-64
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:9489988-Animals,
pubmed-meshheading:9489988-Arteriosclerosis,
pubmed-meshheading:9489988-Blood Vessels,
pubmed-meshheading:9489988-Coronary Artery Disease,
pubmed-meshheading:9489988-Coronary Vessels,
pubmed-meshheading:9489988-Extracellular Matrix,
pubmed-meshheading:9489988-Humans,
pubmed-meshheading:9489988-Immunohistochemistry,
pubmed-meshheading:9489988-Muscle, Smooth, Vascular,
pubmed-meshheading:9489988-Peripheral Vascular Diseases,
pubmed-meshheading:9489988-Proliferating Cell Nuclear Antigen,
pubmed-meshheading:9489988-RNA, Messenger,
pubmed-meshheading:9489988-Rabbits,
pubmed-meshheading:9489988-Recurrence,
pubmed-meshheading:9489988-Thrombospondin 1
|
pubmed:year |
1998
|
pubmed:articleTitle |
Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries.
|
pubmed:affiliation |
Department of Medicine (Cardiology), St. Elizabeth's Medical Center, Tufts University School of Medicine, Boston, MA 02135, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|